Logo image of PSG.DE

PHARMASGP HOLDING SE (PSG.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:PSG - DE000A2P4LJ5 - Common Stock

29 EUR
0 (0%)
Last: 8/11/2025, 7:00:00 PM

PSG.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap348.00M
Revenue(TTM)101.10M
Net Income(TTM)16.40M
Shares12.00M
Float1.03M
52 Week High30
52 Week Low19
Yearly Dividend0.49
Dividend Yield1.76%
EPS(TTM)1.37
PE21.17
Fwd PE15.35
Earnings (Next)09-11
IPO2020-06-19
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
PSG.DE short term performance overview.The bars show the price performance of PSG.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 6 8

PSG.DE long term performance overview.The bars show the price performance of PSG.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of PSG.DE is 29 EUR. In the past month the price increased by 0.69%. In the past year, price increased by 39.42%.

PHARMASGP HOLDING SE / PSG Daily stock chart

PSG.DE Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to PSG.DE. When comparing the yearly performance of all stocks, PSG.DE is one of the better performing stocks in the market, outperforming 86.34% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PSG.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to PSG.DE. PSG.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PSG.DE Financial Highlights

Over the last trailing twelve months PSG.DE reported a non-GAAP Earnings per Share(EPS) of 1.37. The EPS increased by 37.25% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.22%
ROA 13.88%
ROE 44.72%
Debt/Equity 1.58
Chartmill High Growth Momentum
EPS Q2Q%7.89%
Sales Q2Q%10.81%
EPS 1Y (TTM)37.25%
Revenue 1Y (TTM)17.8%

PSG.DE Forecast & Estimates

6 analysts have analysed PSG.DE and the average price target is 38.76 EUR. This implies a price increase of 33.66% is expected in the next year compared to the current price of 29.

For the next year, analysts expect an EPS growth of 28.05% and a revenue growth 15.62% for PSG.DE


Analysts
Analysts80
Price Target38.76 (33.66%)
EPS Next Y28.05%
Revenue Next Year15.62%

PSG.DE Ownership

Ownership
Inst Owners1.95%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About PSG.DE

Company Profile

PSG logo image PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.

Company Info

PHARMASGP HOLDING SE

Lochhamer Schlag 21

Graefelfing BAYERN DE

Employees: 89

PSG Company Website

PSG Investor Relations

Phone: 49898589639150

PHARMASGP HOLDING SE / PSG.DE FAQ

Can you describe the business of PHARMASGP HOLDING SE?

PharmaSGP Holding SE engages in the sale and marketing of non-prescription drugs, chemical-free over-the-counter painkillers, as well as herbal medicines. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2020-06-19. The firm produces and develops non-chemical and over-the-counter drugs and other healthcare products.


What is the stock price of PHARMASGP HOLDING SE today?

The current stock price of PSG.DE is 29 EUR.


Does PSG stock pay dividends?

PHARMASGP HOLDING SE (PSG.DE) has a dividend yield of 1.76%. The yearly dividend amount is currently 0.49.


What is the ChartMill technical and fundamental rating of PSG stock?

PSG.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


How is the market expecting PSG stock to perform?

6 analysts have analysed PSG.DE and the average price target is 38.76 EUR. This implies a price increase of 33.66% is expected in the next year compared to the current price of 29.


When does PHARMASGP HOLDING SE (PSG.DE) report earnings?

PHARMASGP HOLDING SE (PSG.DE) will report earnings on 2025-09-11.


Who owns PHARMASGP HOLDING SE?

You can find the ownership structure of PHARMASGP HOLDING SE (PSG.DE) on the Ownership tab.